
Crinetics Pharmaceuticals Inc
CRNXNASDAQ NMS - GLOBAL MARKETKey Statistics
Open
$35.78
Day High
$36.23
Day Low
$34.79
Prev. Close
$36.01
VolumeShares traded today.
1.62M
Avg. VolumeAverage daily volume.
—
Market CapTotal value of all shares = price × shares outstanding.
$3.75B
P/E (TTM)Price-to-Earnings: share price ÷ earnings per share over the last 12 months. Lower can mean cheaper; very high can mean growth expectations.
-6.93
Forward P/EP/E based on forecast next-year earnings.
—
P/B RatioPrice-to-Book: share price ÷ book value per share.
—
52W HighHighest price over the past 52 weeks.
$57.99
52W LowLowest price over the past 52 weeks.
$25.83
50D MAAverage closing price over the last 50 trading days.
$37.76
200D MAAverage closing price over the last 200 trading days.
$41.46
Dividend YieldAnnual dividend ÷ share price, as a %.
—
BetaVolatility vs the market. >1 = more volatile than the S&P 500.
—
Performance
1W
-4.2%1M
-7.5%6M
-20.5%YTD
-23.9%1Y
+16.5%About
Crinetics Pharmaceuticals is a global pharmaceutical company known for developing drugs for the treatment of endocrine-related diseases. It was founded by Scott Struthers, Frank Zhu, Ana Kusnetzow, and Stephen F. Betz in 2008 and is headquartered in San Diego, California. It went public on NASDAQ in 2018.
www.crinetics.com/Company Facts
Similar stocks
Health CareSentiment
Latest News
Social Noise
Price Alerts
Loading…
Trade CRNX
Brokers available in your region (US)
Affiliate links — we may earn a commission. CFDs are risky.